{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T04:40:27Z","timestamp":1777178427762,"version":"3.51.4"},"reference-count":34,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Given the high incidence and generally favorable prognosis of papillary thyroid microcarcinomas (PTMs), the Porto Proposal aims to refine the management of these tumors. It designates tumors lacking certain risk factors as papillary microtumors (PMTs) to avoid overtreatment and reduce patient stress. The updated Porto Proposal (uPp) suggests criteria for reclassifying incidental PTMs as PMTs. This study seeks to validate these criteria using data from a university hospital in Catalonia, Spain, and assess the clinical and pathological characteristics of PTMs. Methods: This retrospective study analyzed patients diagnosed with PTM (\u22641 cm) at a university hospital from 2000 to 2024. The study examined variables, including lymph node positivity, incidental diagnosis, tumor location, histological type, treatment, multifocality, age at diagnosis, tumor size, and survival. The uPp criteria were applied to reclassify PTMs into PMTs or PMCs (true papillary microcarcinomas). Student\u2019s t-test and chi-square tests were used to evaluate the associations between these variables and the uPp classification. Results: The cohort comprised 107 patients, with 77 (72%) women and 30 men. The mean age at diagnosis was 54.5 years. Out of the total, 77 (72%) cases were reclassified as PMTs and 30 (28%) as PMCs according to the uPp criteria. PMC tumors were larger (mean size 4.5 mm vs. 3.3 mm for PMT, p = 0.014) and were significantly associated with multifocality (52.2%; p = 0.004). Most lymph node-positive cases were classified as PMCs (69.2%; p &lt; 0.001) and were multifocal and bilateral more commonly. However, no significant differences in outcomes between PMCs and PMTs were found (p = 0.188). Follicular histology was significantly more common in PMTs (87.0%, p &lt; 0.001) and rarely had lymph node metastases (4.6%; p = 0.047). Conclusions: The updated Porto Proposal (uPp) effectively identifies PTMs with minimal malignant potential, distinguishing between PMT and PMC. The findings support the protocol\u2019s use in reducing unnecessary treatments and psychological stress for patients. The study highlights significant clinical and pathological differences between PTM subtypes, reinforcing the protocol\u2019s applicability in daily pathological practice.<\/jats:p>","DOI":"10.3390\/cancers17122021","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:45:26Z","timestamp":1750157126000},"page":"2021","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of the Updated Porto Proposal in Papillary Thyroid Microtumors: Analysis of Cases at a University Hospital in Catalonia, Spain"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-6121","authenticated-orcid":false,"given":"Karmele","family":"Saez de Gordoa","sequence":"first","affiliation":[{"name":"Pathology Department, Centre of Biomedical Diagnosis, Hospital Cl\u00ednic, 08036 Barcelona, Spain"},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Tasso","sequence":"additional","affiliation":[{"name":"Pathology Department, Centre of Biomedical Diagnosis, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4460-5220","authenticated-orcid":false,"given":"Alexandre","family":"Rei","sequence":"additional","affiliation":[{"name":"Pathology Department, Centre of Biomedical Diagnosis, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2042-3362","authenticated-orcid":false,"given":"Martin","family":"Ramonda","sequence":"additional","affiliation":[{"name":"Pathology Department, Centre of Biomedical Diagnosis, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Salinas","sequence":"additional","affiliation":[{"name":"Pathology Department, Centre of Biomedical Diagnosis, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Cobo-Lopez","sequence":"additional","affiliation":[{"name":"Pathology Department, Centre of Biomedical Diagnosis, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Orois","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Clinic Institute of Digestive and Metabolic Diseases, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Cobo","sequence":"additional","affiliation":[{"name":"Radiodiagnosis Department, Imaging Diagnostic Center, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6861-6982","authenticated-orcid":false,"given":"Marti","family":"Manyalich-Blasi","sequence":"additional","affiliation":[{"name":"Surgery Department, Clinic Institute of Digestive and Metabolic Diseases, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ram\u00f3n y Cajal","sequence":"additional","affiliation":[{"name":"Oncology Department, Institute of Cancer and Blood Diseases, Hospital Cl\u00ednic, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Mora","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Clinic Institute of Digestive and Metabolic Diseases, Hospital Cl\u00ednic, 08036 Barcelona, Spain"},{"name":"Medicine Department, University of Barcelona (UB), 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Hanzu","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Clinic Institute of Digestive and Metabolic Diseases, Hospital Cl\u00ednic, 08036 Barcelona, Spain"},{"name":"Medicine Department, University of Barcelona (UB), 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Vidal P\u00e9rez","sequence":"additional","affiliation":[{"name":"Surgery Department, Clinic Institute of Digestive and Metabolic Diseases, Hospital Cl\u00ednic, 08036 Barcelona, Spain"},{"name":"Surgery and Surgical Specialties Department, University of Barcelona (UB), 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6675-3425","authenticated-orcid":false,"given":"Maria Teresa","family":"Rodrigo-Calvo","sequence":"additional","affiliation":[{"name":"Pathology Department, Centre of Biomedical Diagnosis, Hospital Cl\u00ednic, 08036 Barcelona, Spain"},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi I Sunyer (IDIBAPS), 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO Classification of Thyroid Neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.29251","article-title":"Thyroid Cancer Mortality and Incidence: A Global Overview","volume":"136","author":"Malvezzi","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12020-024-03907-z","article-title":"Thyrotropin (TSH) and Thyroid Autoimmunity Are Predictive Factors for the Incidental Discovery of Papillary Thyroid Microcarcinoma during Thyroidectomy","volume":"86","author":"Kyrilli","year":"2024","journal-title":"Endocrine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MNM.0000000000000991","article-title":"Clinical Features and Therapeutic Outcomes of Patients with Papillary Thyroid Microcarcinomas and Larger Tumors","volume":"40","author":"Zheng","year":"2019","journal-title":"Nucl. Med. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101630","DOI":"10.1016\/j.beem.2022.101630","article-title":"Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma","volume":"37","author":"Sugitani","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liang, Y., Fan, E.X., Zhang, J., Xu, T., Song, J., Huang, F., and Wang, D. (2024). Construction and Validation of a Diagnostic Model for High-Risk Papillary Thyroid Microcarcinoma. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1431584"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/106689690301100401","article-title":"Renaming Papillary Microcarcinoma of the Thyroid Gland: The Porto Proposal","volume":"11","author":"Rosai","year":"2003","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/PAS.0000000000001522","article-title":"Thyroid Papillary Microtumor Validation of the (Updated) Porto Proposal Assessing Sex Hormone Receptor Expression and Mutational BRAF Gene Status","volume":"44","author":"Aliyev","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/cen.14529","article-title":"Papillary Thyroid Microcarcinoma: Is Active Surveillance Always Enough?","volume":"95","author":"Sutherland","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1089\/thy.2013.0154","article-title":"Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathologic Features with BRAFV600E Mutational Analysis","volume":"23","author":"Bernstein","year":"2013","journal-title":"Thyroid"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/cncr.22912","article-title":"BRAFV600E Mutation and P27kip1 Expression in Papillary Carcinomas of the Thyroid \u22641 Cm and Their Paired Lymph Node Metastases","volume":"110","author":"Rodolico","year":"2007","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/ERC-14-0531","article-title":"BRAFV600E Mutation in Papillary Thyroid Microcarcinoma: A Meta-Analysis","volume":"22","author":"Li","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/thy.2015.0391","article-title":"BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis","volume":"26","author":"Chen","year":"2016","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1089\/thy.2015.0116","article-title":"The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource Countries","volume":"25","author":"Vaccarella","year":"2015","journal-title":"Thyroid"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Slijepcevic, N., Zivaljevic, V., Marinkovic, J., Sipetic, S., Diklic, A., and Paunovic, I. (2015). Retrospective Evaluation of the Incidental Finding of 403 Papillary Thyroid Microcarcinomas in 2466 Patients Undergoing Thyroid Surgery for Presumed Benign Thyroid Disease. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1352-4"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/curroncol31020070","article-title":"Papillary Thyroid Microcarcinoma: Differences between Lesions in Incidental and Nonincidental Settings\u2014Considerations on These Clinical Entities and Personal Experience","volume":"31","author":"Lucandri","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CCO.0000000000000595","article-title":"Papillary Thyroid Microcarcinoma: Optimal Management versus Overtreatment","volume":"32","author":"Walgama","year":"2020","journal-title":"Curr. Opin. Oncol."},{"key":"ref_18","first-page":"142","article-title":"Incidental Papillary Thyroid Microcarcinoma in Consecutive Patients Undergoing Thyroid Surgery for Benign Disease. A Single Center Experience","volume":"94","author":"Spaziani","year":"2023","journal-title":"Ann. Ital. Chir."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1210\/jc.2013-2118","article-title":"Differences in the Recurrence and Mortality Outcomes Rates of Incidental and Nonincidental Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis of 21 329 Person-Years of Follow-Up","volume":"99","author":"Mehanna","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bjorl.2020.05.004","article-title":"Clinicopathologic Factors and Preoperative Ultrasonographic Characteristics for Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Single Center Retrospective Study","volume":"88","author":"Jiwang","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15537\/smj.2024.45.3.20230638","article-title":"Papillary Thyroid Microcarcinoma with and without Nodal Metastasis A Comparative Analysis","volume":"45","author":"Alqaryan","year":"2024","journal-title":"Saudi Med. J."},{"key":"ref_22","first-page":"103023","article-title":"Papillary Thyroid Microcarcinomas That Metastasize to Lymph Nodes","volume":"42","author":"Dirikoc","year":"2021","journal-title":"Am. J. Otolaryngol. Head Neck Med. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shi, C., Guo, Y., Lv, Y., Nanding, A., Shi, T., Qin, H., and He, J. (2016). Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167414"},{"key":"ref_24","first-page":"138","article-title":"Encapsulation Status of Papillary Thyroid Microcarcinomas Is Associated with the Risk of Lymph Node Metastases and Tumor Multifocality","volume":"46","author":"Cupisti","year":"2014","journal-title":"Horm. Metab. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13304-024-01779-6","article-title":"Papillary Thyroid Carcinoma: \u2264 10 Mm Does Not Always Mean PN0. A Multicentric Real-World Study","volume":"76","author":"Amendola","year":"2024","journal-title":"Updates Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ecl.2018.10.006","article-title":"Management of Papillary Thyroid Microcarcinoma","volume":"48","author":"Brito","year":"2019","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000516469","article-title":"European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions","volume":"10","author":"Mauri","year":"2021","journal-title":"Eur. Thyroid J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Faro, F.N., Bertelli, A.A.T., Scalissi, N.M., Cury, A.N., Padovani, R.D.P., and Ferraz, C. (2024). Active Surveillance versus Immediate Surgery in the Management of Low-Risk Papillary Thyroid Microcarcinoma: Comparison of Long-Term Costs in Brazil. Arch. Endocrinol. Metab., 68.","DOI":"10.20945\/2359-4292-2023-0349"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.suronc.2019.05.011","article-title":"The Overuse of Radioactive Iodine in Low-Risk Papillary Thyroid Cancer Patients","volume":"29","author":"Moten","year":"2019","journal-title":"Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jc.2017-01775","article-title":"High Serum TSH Level Is Associated with Progression of Papillary Thyroid Microcarcinoma during Active Surveillance","volume":"103","author":"Kim","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/a-2008-0824","article-title":"Papillary Thyroid Microcarcinoma: Insights from a Cohort of 257 Thyroidectomized Patients","volume":"55","author":"Scherer","year":"2023","journal-title":"Horm. Metab. Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/12\/2021\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:53:43Z","timestamp":1760032423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/12\/2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["cancers17122021"],"URL":"https:\/\/doi.org\/10.3390\/cancers17122021","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}